Johnson & Johnson

Cartoon of businessmen standing around a broken target
Biotech

BMS-J&J blood thinner fails phase 3, denting blockbuster hopes

The partners stopped the phase 3 early for futility, closing off one avenue to market for a molecule tipped to generate multibillion-dollar sales.
Nick Paul Taylor Nov 14, 2025 8:10am
Legend
Favicon Fierce Pharma

J&J, Legend pull ASH paper comparing Carvykti to rival CAR-T

Nov 12, 2025 11:36am
Martin Makary FDA Senate HELP confirmation

FDA reveals 2nd round of 'national priority' voucher winners

Nov 6, 2025 3:12pm
Halloween deal shake hands zombie

Nanobiotix finds new way to source cash from J&J-partnered drug

Oct 31, 2025 6:05am
Nvidias Endeavor building in Santa Clara California

J&J MedTech, Verily pen Nvidia deals

Oct 29, 2025 8:45am
JNJ

J&J reveals plan to spin off its $9B orthopedics business

Oct 14, 2025 11:30am